GlassScriptPhysician profile
Brenda Worcester
NPI 1710364765
$3,665.83
in general payments reported to CMS, 2019-2025
23 companies · $951 in 2025
The $951 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $760 · 2022: $489 · 2023: $888 · 2024: $578 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,416.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.42 | 2021-2024 | |
| Esperion Therapeutics, INC. | $284.89 | 2021 | |
| Novo Nordisk INC | $262.62 | 2021-2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $246.15 | 2021-2023 | Austedo Xr |
| Vertos Medical, INC. | $241.91 | 2024 | Mild Device Kit |
| Medtronic, INC. | $239.27 | 2021 | |
| Gilead Sciences, INC. | $207.39 | 2022-2023 | Veklury |
| Edwards Lifesciences Corporation | $165.49 | 2025 | Sapien 3 Ultra Resilia |
| Idorsia Pharmaceuticals US INC | $159.52 | 2022-2023 | Quviviq |
| Grifols USA, LLC | $140.58 | 2025 | Xembify |
| Biotronik Nro, INC. | $135.40 | 2025 | Prospera |
| Evoke Pharma, INC. | $125.00 | 2023 | Gimoti |
| Aimmune Therapeutics, INC. | $123.97 | 2025 | Zenpep |
| Alexion Pharmaceuticals, INC. | $121.65 | 2024 | Ultomiris |
| Genzyme Corporation | $116.30 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $115.02 | 2022 | |
| Abiomed | $112.17 | 2022 | |
| Sanofi-Aventis U.S. LLC | $108.92 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $104.36 | 2024 | Airsupra |
| Boston Scientific Corporation | $93.88 | 2025 | Watchman Access System |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $91.95 | 2023 | |
| Exact Sciences Corporation | $89.49 | 2025 | The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $89.48 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Worcester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.